<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN" "http://jats.nlm.nih.gov/publishing/1.1d1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JPHIA</journal-id>
<journal-title-group>
<journal-title>Journal of Public Health in Africa</journal-title>
</journal-title-group>
<issn pub-type="ppub">2038-9922</issn>
<issn pub-type="epub">2038-9930</issn>
<publisher>
<publisher-name>AOSIS</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">JPHIA-16-733</article-id>
<article-id pub-id-type="doi">10.4102/jphia.v16i1.733</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>What are our options for mortality data collection and how can they provide HIV-specific information?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5623-8745</contrib-id>
<name>
<surname>Sulpizio</surname>
<given-names>Carlie L.</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-8386-5761</contrib-id>
<name>
<surname>Tessema</surname>
<given-names>Zaena</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1299-5204</contrib-id>
<name>
<surname>Morof</surname>
<given-names>Diane</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6354-6818</contrib-id>
<name>
<surname>Boyd</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7865-5950</contrib-id>
<name>
<surname>Agyemang</surname>
<given-names>Elfriede</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4264-1642</contrib-id>
<name>
<surname>Knuth</surname>
<given-names>Martha</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3717-236X</contrib-id>
<name>
<surname>Fernandez</surname>
<given-names>Danielle</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4840-1914</contrib-id>
<name>
<surname>Patel</surname>
<given-names>Monita</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7722-2486</contrib-id>
<name>
<surname>Ali</surname>
<given-names>Hammad</given-names>
</name>
<xref ref-type="aff" rid="AF0001">1</xref>
</contrib>
<aff id="AF0001"><label>1</label>Division of Global HIV and Tuberculosis, United States (US) Centers for Disease Control and Prevention, Atlanta, GA, United States of America</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><bold>Corresponding author:</bold> Carlie Sulpizio, <email xlink:href="sulpizic@unc.edu">sulpizic@unc.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub"><day>27</day><month>05</month><year>2025</year></pub-date>
<pub-date pub-type="collection"><year>2025</year></pub-date>
<volume>16</volume>
<issue>1</issue>
<elocation-id>733</elocation-id>
<history>
<date date-type="received"><day>24</day><month>07</month><year>2024</year></date>
<date date-type="accepted"><day>11</day><month>12</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2025. The Authors</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.</license-p>
</license>
</permissions>
<abstract>
<sec id="st1">
<title>Background</title>
<p>Mortality data are critical for understanding changes in population health, detecting and monitoring diseases, guiding public health responses and evaluating interventions like human immunodeficiency viruses (HIV) prevention and treatment programmes. However, in low- and middle-income countries (LMICs), comprehensive mortality data are often hindered by a high incidence of deaths occurring outside healthcare facilities and the lack of robust data systems, creating a significant knowledge gap.</p>
</sec>
<sec id="st2">
<title>Aim</title>
<p>This article presents methodologies for collecting mortality data, particularly in LMICs, to provide accurate and reliable information on overall and cause-specific mortality, including HIV-related deaths.</p>
</sec>
<sec id="st3">
<title>Setting</title>
<p>This study explore methods that may be useful in LMICs, where mortality data systems are often ad-hoc, sub-national and incomplete.</p>
</sec>
<sec id="st4">
<title>Method</title>
<p>Available methods were examined for collecting mortality data and report on the strengths, weaknesses and resource considerations for each method.</p>
</sec>
<sec id="st5">
<title>Results</title>
<p>The analysis shows that while Civil Registration and Vital Statistics is the gold standard for mortality data collection, its implementation is challenging because of differing priorities of stakeholders, infrastructural and legal barriers. Alternative methods may provide valuable data but may have limitations in coverage and resource allocation. Integrating these methods can enhance understanding of mortality data, including for HIV-related deaths.</p>
</sec>
<sec id="st6">
<title>Conclusion</title>
<p>Implementing a combination of mortality data-collection methods could address gaps in mortality data in LMICs. Tailoring interventions based on these data may improve health outcomes and support HIV epidemic control efforts.</p>
</sec>
<sec id="st7">
<title>Contribution</title>
<p>This study could be used as a resource to ministries of health, national and international public health organisations, researchers and funding bodies as it can assist countries in selecting the mortality surveillance strategy that best fits their HIV epidemic, and available infrastructure and financial resources.</p>
</sec>
</abstract>
<kwd-group>
<kwd>HIV/AIDS</kwd>
<kwd>mortality</kwd>
<kwd>surveillance</kwd>
<kwd>data collection</kwd>
<kwd>civil Registration</kwd>
<kwd>vital statistics</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding information</bold> The authors reported that they received funding from the U.S. President&#x2019;s Emergency Plan for AIDS Relief through the U.S. Centers for Disease Control and Prevention, which may be affected by the research reported in the enclosed publication. The authors have disclosed those interests fully and have implemented an approved plan for managing any potential conflicts arising from their involvement. The terms of these funding arrangements have been reviewed and approved by the affiliated university in accordance with its policy on objectivity in research.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec id="s0001">
<title>Background</title>
<p>Mortality data, when viewed comprehensively, can uncover changes in population health status over time and can be obtained through various methods to help understand these changes, including the ability to detect the initial cases of infectious diseases, monitor preventable diseases, implement public health response, raise awareness and provide insights to prevent further deaths. Mortality data help identify the causes and circumstances of death and thus provide essential information for an evidence-based response to changes in population health status.<sup><xref ref-type="bibr" rid="CIT0001">1</xref>,<xref ref-type="bibr" rid="CIT0002">2</xref>,<xref ref-type="bibr" rid="CIT0003">3</xref></sup> Cause of death (CoD) is the official determination of the condition leading to death. Cause of death is currently classified using the International Statistical of Diseases and Related Health Problems (ICD) codes.<sup><xref ref-type="bibr" rid="CIT0004">4</xref></sup> International Statistical Classification of Diseases and Related Health Problems is the base used for mortality coding and classification for diseases, disorders, injuries and other health-related conditions with multiple uses such as on death certificates or use by healthcare centres for billing. Currently, routinely available mortality data are limited in most low- and middle-income countries (LMICs) since most deaths occur at home in these settings.<sup><xref ref-type="bibr" rid="CIT0005">5</xref></sup> Where implemented, the mortality data systems are ad-hoc or sub-national, and the CoD data are incomplete or unreliable.<sup><xref ref-type="bibr" rid="CIT0006">6</xref></sup> Data quality is low for 85 countries capturing CoD data; and 74 countries, predominately in sub-Saharan Africa, do not capture mortality data in a routine surveillance system.<sup><xref ref-type="bibr" rid="CIT0007">7</xref></sup></p>
<p>Mortality data can also assist in assessing the impact of human immunodeficiency viruses (HIV) prevention and antiretroviral therapy (ART) treatment programmes. Trend data on HIV-related deaths can help HIV programmes determine if deaths among people living with HIV are increasing, decreasing or remaining stable. This information, along with CoD information, can help countries design or improve their existing HIV programmes and improve patient outcomes, such as viral suppression.</p>
<p>Implementing mortality systems is also important as they, in combination with information on new infections, can assist in improving our understanding of HIV epidemic control.<sup><xref ref-type="bibr" rid="CIT0007">7</xref></sup> One of the definitions of epidemic control is the point at which the total number of new HIV infections falls below the total number of deaths from all causes among HIV-infected individuals while both exhibit a declining trend (additional conditions for using this metric include a minimum ART uptake of 70&#x0025; and a falling trend of new HIV infections). As countries get closer to HIV epidemic control, it is critical to understand the remaining burden and find creative solutions to HIV prevention, care and treatment. The lack of accurate mortality data can potentially hinder countries documenting HIV epidemic control. Currently, mortality data among people living with HIV, especially in countries in sub-Saharan Africa, come from either reporting death from the next of kin to the healthcare facility (which is limited) or through the follow-up of patients that miss their clinical appointments. Many deaths are missed in both these cases, and CoD information is generally not available. Therefore, mortality estimates for many LMICs, including most countries in sub-Saharan Africa, are based on modelling (e.g. Spectrum model for HIV, which is used to generate annual HIV estimates in 170 countries).<sup><xref ref-type="bibr" rid="CIT0008">8</xref></sup></p>
<p>There is a dearth of published papers that provide information on methods to collect mortality data. Here we aim to describe various methods, listed further in the text, that can be utilised to gather mortality data.<sup><xref ref-type="bibr" rid="CIT0009">9</xref></sup> These methods provide mortality data, including overall and cause-specific mortality rates and trends, and CoD information including HIV as the CoD. Strengths and weaknesses, along with resource and implementation considerations, of each method are described in <xref ref-type="table" rid="T0001">Table 1</xref>.</p>
<table-wrap id="T0001">
<label>TABLE 1</label>
<caption><p>Strengths, weaknesses, availability of cause of death and representativeness of different mortality data-collection methods.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Type of system</th>
<th valign="top" align="left">Strengths</th>
<th valign="top" align="left">Weaknesses</th>
<th valign="top" align="left">Cause of death</th>
<th valign="top" align="left">Representativeness</th>
<th valign="top" align="left">Implementation considerations</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">CRVS</td>
<td align="left">Gold standard for mortality data; can produce ongoing cause-specific mortality trends comparable over time and geographic area</td>
<td align="left">CoD data reported to CRVS are frequently not available, inconsistent or the quality of data is unreliable; is resource-intensive and only works well with complete or near-complete coverage</td>
<td align="left">CoD available if medical certification of death is entered into the CRVS</td>
<td align="left">National coverage</td>
<td align="left">Depends on scale of implementation (national/sentinel) <italic>where CRVS exists in some form:</italic> SWOT analysis; stakeholder meetings; data extraction; data analysis; dissemination</td>
</tr>
<tr>
<td align="left">Burial systems</td>
<td align="left">Captures all deaths, including community deaths that are brought to burial sites; can be supplemented with VA</td>
<td align="left">Deaths not brought to registered burial sites are missed; VA-related weaknesses if VA is conducted</td>
<td align="left">All CoD may be available if VA is conducted</td>
<td align="left">Depends on the coverage</td>
<td align="left">Training; human resources; development of tools and registers; monitoring; data entry; data analysis; dissemination</td>
</tr>
<tr>
<td align="left">Household surveys with mortality modules</td>
<td align="left">Wide variety of survey methods; can be added as a supplement to an existing survey</td>
<td align="left">Requires skilled and trained interviewers and adequate financial resources; may require additional resources if VA is included in a second survey phase</td>
<td align="left">All CoD may be available if VA is conducted</td>
<td align="left">May be representative based on sampling approach</td>
<td align="left">Training; human resources; development of surveys; field/data collection; data management; data entry; data analysis; dissemination</td>
</tr>
<tr>
<td align="left">Hospital data on cause-specific mortality</td>
<td align="left">Uses existing data; can be combined with community-based mortality data sources to improve representativeness</td>
<td align="left">Does not capture community deaths if used alone; absence of ICD-trained professionals may contribute to limited or inaccurate coding</td>
<td align="left">CoD available through medical records</td>
<td align="left">May be representative based on coverage of facilities</td>
<td align="left">Training; human resources; development of tools; data entry; monitoring; data analysis; dissemination</td>
</tr>
<tr>
<td align="left">LTFU tracking</td>
<td align="left">Uses existing HIV programme data; can support efforts to re-link people living with HIV LTFU back into care and treatment services</td>
<td align="left">Only captures mortality among people living with HIV on treatment; needs to be supplemented with VA to assign a CoD if not available through medical records</td>
<td align="left">CoD only available if medically certified CoD is provided by next of kin</td>
<td align="left">May be representative of all people living with HIV on treatment if all sites are included</td>
<td align="left">Training; human resources; development of tools; communication; transport; data entry; data analysis; dissemination</td>
</tr>
<tr>
<td align="left">HIV CS</td>
<td align="left">Provides unique information on HIV mortality and can help define epidemic control; consists of routine reporting of longitudinal individual-level data; facilitates HIV programmes to monitor and address gaps</td>
<td align="left">Most low- and middle-income countries rarely collect mortality data, including CoD; lack of mortality data hinders the measurement of epidemic control</td>
<td align="left">CoD only available if the country collects mortality data or links from other data systems</td>
<td align="left">Depends on the coverage</td>
<td align="left">Training and capacity building; human resources; development of data tools; communication and coordination; transport and logistics; data collection; data integration; data analysis; dissemination</td>
</tr>
<tr>
<td align="left">Autopsy</td>
<td align="left">Most reliable method of CoD determination</td>
<td align="left">Resource-intensive; time-consuming; conducted by trained medical professionals</td>
<td align="left">Conducted to determine CoD</td>
<td align="left">Depends on the coverage</td>
<td align="left">Training (including verbal autopsy training); human resources; development of tools; field/data collection; ethical considerations; data entry; data analysis; dissemination; quality assurance</td>
</tr>
<tr>
<td align="left">VA</td>
<td align="left">Can be used when deaths are not assigned a medical certificate of CoD, as in the cases of poorly functioning healthcare systems or deaths that occur in the community</td>
<td align="left">Requires skilled and trained interviewers, data entry and database support and either physician-coded or automated assignment of CoD; can be inaccurate for certain causes (e.g., TB)<sup><xref ref-type="bibr" rid="CIT0036">36</xref></sup></td>
<td align="left">All CoD available from VA</td>
<td align="left">Depends on the coverage</td>
<td align="left">Training (including CoD training); human resource; development of data tools; field/data collection; data entry; data analysis; dissemination</td>
</tr>
<tr>
<td align="left">SAAVY</td>
<td align="left">Can be representative of larger geographic or administrative area if statistical sampling scheme is used; requires fewer resources compared to full CRVS</td>
<td align="left">Same as VA</td>
<td align="left">All CoD available from VA</td>
<td align="left">May be representative based on sampling approach</td>
<td align="left">Same as CRVS and Verbal Autopsy</td>
</tr>
<tr>
<td align="left">MIA/MITS</td>
<td align="left">Sensitive in determining CoD compared to full post-mortem autopsies for infectious causes; less costly and time-consuming and more acceptable than full autopsy</td>
<td align="left">Requires that pathology and laboratory infrastructure and personnel be in place (or be developed); less useful for non-infectious causes compared to full autopsy</td>
<td align="left">CoD available based on the tests conducted on cadaver samples</td>
<td align="left">Depends on the coverage</td>
<td align="left">Training; human resources; equipment; development of tools; field/sample collection; sample transport; laboratory testing; data entry; data analysis; dissemination</td>
</tr>
<tr>
<td align="left">HIV biomarker surveillance in mortuaries</td>
<td align="left">Only blood or oral fluid/saliva is collected, making specimen collection easier than MIA; can provide information on underlying (undiagnosed) HIV disease, ART status, and viral suppression</td>
<td align="left">May require trained staff that can collect blood from the cadaver; if conducted in mortuaries, it may be limited to urban settings where the majority of mortuaries exist</td>
<td align="left">Only available if extracted through medical records</td>
<td align="left">Not representative</td>
<td align="left">Training; human resources; equipment; development of tools; field/sample collection; sample transport; laboratory testing; data entry; data analysis; dissemination</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>CRVS, Civil Registration and Vital Statistics; CoD, cause of death; SWOT, Strengths, weaknesses, opportunities and threats; VA, verbal autopsy; ICD, International Statistical Classification of Diseases and Related Health Problems; LTFU, loss to follow-up; HIV, human immunodeficiency viruses; CS, case surveillance; TB, tuberculosis; SAAVY, Sample Vital Registration with verbal autopsy; MIA, minimally invasive autopsy; MITS, Minimally Invasive Tissue Sampling; ART, antiretroviral therapy.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s0002">
<title>Civil registration and vital statistics</title>
<p>Civil registration is defined as the continuous, permanent, compulsory and universal recording of vital events (births and deaths) pertaining to the population, as provided through decrees or regulations in accordance with the legal requirements in a country.<sup><xref ref-type="bibr" rid="CIT0010">10</xref></sup> Establishing a legal requirement obliges all citizens to abide by said requirement so that burials cannot take place if the death is not registered.<sup><xref ref-type="bibr" rid="CIT0007">7</xref></sup> Civil Registration and Vital Statistics (CRVS) systems &#x2013; when fully functional, with national coverage, and including CoD &#x2013; are the gold standard for assessing mortality rates and trends in a country. A national CRVS system includes registration of all deaths, irrespective of location, along with medically certified CoD. Data captured by the CRVS system can generate continuous information on health indicators, help understand the prevalence, distribution and causes of mortality, as well as the health inequities affecting mortality to inform programmatic and policy decisions. Many LMICs record vital events including births and deaths, but they may not cover the entire population, generate data on a continuing basis, capture accurate CoD especially for those dying outside of health facilities or be linked electronically.<sup><xref ref-type="bibr" rid="CIT0006">6</xref>,<xref ref-type="bibr" rid="CIT0011">11</xref></sup> Therefore, these countries cannot compile data for accurate, detailed and ongoing analyses. Cause of death is a critical part of CRVS and should ideally come from medical certification. However, many countries fail to capture accurate CoD because of a lack of medical certification of deaths which can be because of multiple factors including lack of training for deaths occurring at health facilities and no clinical oversight for deaths occurring in the community. A high-functioning national CRVS system remains the gold standard for national mortality surveillance; however, achieving such a system is complicated by legal mandates, infrastructure and differing priorities of stakeholders.<sup><xref ref-type="bibr" rid="CIT0006">6</xref></sup></p>
<p>For HIV, CRVS systems can help assess the impact of HIV programmes and treatment on mortality in the total population. In many countries without a CRVS system, many deaths that occur outside of health facilities are not counted, thus leaving gaps in mortality data.<sup><xref ref-type="bibr" rid="CIT0007">7</xref>,<xref ref-type="bibr" rid="CIT0012">12</xref></sup> Therefore, maintaining comprehensive CRVS includes necessary infrastructure, community participation and medical certification of CoD. Countries could conduct national assessments of their CRVS system and develop strategies to address gaps in mortality data.</p>
</sec>
<sec id="s0003">
<title>Burial systems surveillance</title>
<p>Mortality surveillance can be conducted with engagement of staff at burial sites. Each death brought to the burial site is registered in the surveillance system and basic demographic information is collected as part of registration. Cause of death is recorded if the cadaver has been brought from a healthcare facility or a mortuary (in case an autopsy is conducted at the mortuary). For cadavers brought from the community, verbal autopsy (VA) may be conducted by trained personnel to determine the CoD. Burial systems surveillance can also be used to calculate mortality trends using local population size.<sup><xref ref-type="bibr" rid="CIT0013">13</xref>,<xref ref-type="bibr" rid="CIT0014">14</xref></sup></p>
</sec>
<sec id="s0004">
<title>Household surveys with mortality modules</title>
<p>In countries without medical certification of CoD or CRVS, mortality questions added to household surveys may provide a framework to understand the leading CoD in a population.<sup><xref ref-type="bibr" rid="CIT0007">7</xref>,<xref ref-type="bibr" rid="CIT0015">15</xref></sup> Although VA modules are the most commonly used method to collect information on CoD in household surveys, supplemental methods may include a follow-up survey or a post-census survey.<sup><xref ref-type="bibr" rid="CIT0007">7</xref></sup> Follow-up surveys typically take place within a year of a death identified through the initial survey.<sup><xref ref-type="bibr" rid="CIT0016">16</xref></sup> Some countries may include additional modules such as the social autopsy, which identifies situations that may have affected mortality risk. Results from additional questionnaires help inform future survey methodology and strategies to improve mortality data capture.<sup><xref ref-type="bibr" rid="CIT0017">17</xref></sup> Post-census surveys are similar to follow-up surveys with the key difference being that in post-census surveys, deaths are identified through a census, and a sample of households with recorded deaths are followed up with VA interviews.</p>
</sec>
<sec id="s0005">
<title>Hospital data on cause-specific mortality</title>
<p>Routinely collected hospital data are a main source of cause-specific mortality statistics. Hospital data on cause-specific mortality are guided by the following HIV mortality principles: (1) recording deaths individually by patient age, sex, CoD and location of the hospital, (2) recording deaths in line with ICD principles when more than one cause is reported, (3) maintaining confidentiality and (4) sharing local mortality statistics with certifying clinicians.<sup><xref ref-type="bibr" rid="CIT0007">7</xref></sup> Clinical staff are trained on proper reporting of diagnosis and CoD data. Decision tables may also help staff accurately identify complicated underlying CoD.<sup><xref ref-type="bibr" rid="CIT0018">18</xref></sup> Hospitals can consider creating a local ICD coding index categorising the most frequent diagnoses and including comorbidities and sequences of events leading to death.<sup><xref ref-type="bibr" rid="CIT0019">19</xref>,<xref ref-type="bibr" rid="CIT0020">20</xref>,<xref ref-type="bibr" rid="CIT0021">21</xref></sup></p>
</sec>
<sec id="s0006">
<title>Loss to follow-up tracking</title>
<p>Loss to follow-up (LTFU) tracking is a method specific to HIV treatment programmes, although it can be utilised for other CoD including tuberculosis (TB). Many deaths among people living with HIV which occur outside the healthcare system go unreported and are incorrectly deemed &#x2018;lost to follow-up&#x2019; in HIV programme data; this can lead to incorrect mortality estimates among people living with HIV receiving HIV services.<sup><xref ref-type="bibr" rid="CIT0022">22</xref>,<xref ref-type="bibr" rid="CIT0023">23</xref></sup> A few methods have been proposed to correct mortality estimates.<sup><xref ref-type="bibr" rid="CIT0023">23</xref></sup> In settings with active death registration systems, notified deaths can be linked to the patient&#x2019;s ART records, allowing documentation of the outcome of the LTFU tracking.<sup><xref ref-type="bibr" rid="CIT0006">6</xref>,<xref ref-type="bibr" rid="CIT0024">24</xref></sup> In settings without adequate civil registration records or with incomplete, low-quality CoD data, tracing of individuals LTFU can be used to determine the current status and reason(s) for interruptions of treatment by surveillance and/or clinic staff via phone calls, home visits or social networks.<sup><xref ref-type="bibr" rid="CIT0023">23</xref>,<xref ref-type="bibr" rid="CIT0025">25</xref></sup> If the death of an individual who has been LTFU is confirmed, the civil record can be updated by submitting a death report form to the national death registry, and mortality estimates can be adjusted accordingly. In addition to helping improve HIV mortality estimates, LTFU tracking is crucial to people living with HIV monitoring and improving their clinical outcomes.</p>
</sec>
<sec id="s0007">
<title>Human immunodeficiency viruses case surveillance</title>
<p>For HIV-specific mortality surveillance, mortality status, along with CoD, can be included as a part of existing HIV case surveillance (CS) systems. Human immunodeficiency viruses case surveillance consists of routine reporting of longitudinal individual-level data on all people living with HIV in a population from the point of diagnosis and through the cascade of sentinel events including treatment, viral suppression and death. Routine CS facilitates HIV programmes to monitor and address gaps in HIV service delivery and health outcomes, including mortality, among people living with HIV. However, CS systems are currently limited in scale in most LMICs, rarely collect mortality data, including CoD and face similar challenges as LTFU. When CS systems are limited or do not collect mortality data systematically, data from other mortality systems can be linked to CS to inform mortality data or bridge gaps in mortality data in CS. Designing an HIV CS system depends on the country context. Availability of well-established patient management systems facilitates reporting of data from sentinel events, including death, in the design of CS systems. Mortality data in HIV CS can assist in understanding the factors that contribute to mortality in HIV-positive individuals.<sup><xref ref-type="bibr" rid="CIT0011">11</xref>,<xref ref-type="bibr" rid="CIT0026">26</xref></sup></p>
</sec>
<sec id="s0008">
<title>Autopsy</title>
<p>An autopsy is a surgical examination of a body to determine the cause and manner of death or to evaluate any disease or injury. Although histological examination related to autopsy is the most reliable method of determining CoD, an autopsy is not commonly used especially in LMICs, as autopsies are time-consuming and are conducted by trained medical professionals.<sup><xref ref-type="bibr" rid="CIT0027">27</xref></sup> In many LMICs, autopsies are only performed for medico-legal cases or upon request of the family of the deceased.</p>
</sec>
<sec id="s0009">
<title>Verbal autopsy</title>
<p>Verbal autopsy is an interview-based method, used to determine the probable CoD, in which an interview is conducted with the next of kin or caregivers after a death occurs outside of a healthcare setting.<sup><xref ref-type="bibr" rid="CIT0028">28</xref></sup> The interview, normally conducted by a trained field worker, is guided by a structured survey and gathers information on signs and symptoms related to illnesses exhibited by the deceased prior to death.<sup><xref ref-type="bibr" rid="CIT0029">29</xref></sup> For HIV, the VA questionnaire asks if the deceased ever had a positive HIV test or was diagnosed with AIDS, among other questions. Data are then analysed by physicians or automated computerised models to assign probable CoD. Many studies have been conducted to validate various VA approaches in the absence of CRVS, ranging from physician review of VA to automated and data-derived algorithms. For comparability, there are standaridsed VA guidance and data-collection instruments.<sup><xref ref-type="bibr" rid="CIT0028">28</xref>,<xref ref-type="bibr" rid="CIT0030">30</xref>,<xref ref-type="bibr" rid="CIT0031">31</xref>,<xref ref-type="bibr" rid="CIT0032">32</xref></sup> Resources for training, evaluation and careful ethical consideration when discussing death in various cultures and populations are important in creation and maintenance of a successful VA system.<sup><xref ref-type="bibr" rid="CIT0033">33</xref></sup></p>
</sec>
<sec id="s0010">
<title>Sample vital registration with verbal autopsy</title>
<p>Sample vital registration with verbal autopsy (SAAVY), although not a long-term replacement for CRVS, can provide birth, death and CoD data needed for policy and programmes. Sample vital registration with verbal autopsy is a combination of CRVS and VA where vital event registration is completed in a sample of surveillance areas. Verbal autopsy is used to determine the CoD for deaths in a sample of surveillance sites, selected through probability sampling (as opposed to national coverage for CRVS). Following the selection of sites, a census is conducted at each site to gather baseline information about the population. Key informants in each site routinely monitor and report vital events and a VA is conducted for every death. The key difference between SAVVY and CRVS is that CRVS systems should have national coverage and be routine and ongoing, whereas SAVVY is done in a sample of surveillance sites.</p>
</sec>
<sec id="s0011">
<title>Biomarker-based sentinel surveillance</title>
<p>Full autopsies are considered the gold standard for determining CoD; however, they are cumbersome, require expertise and resources and have low acceptability. Autopsies, and associated testing, can help identify HIV in undiagnosed individuals and determine HIV-related CoD. In place of full autopsies, biomarker-based sentinel surveillance can provide trends in cause-specific mortality and can be conducted in two ways.</p>
<sec id="s20012">
<title>Minimally invasive autopsy/minimally invasive tissue sampling</title>
<p>Minimally invasive autopsy (MIA)/minimally invasive tissue sampling (MITS) is a histopathological and biomarker testing of tissue and non-tissue samples, including body fluids, collected from a cadaver through minimally invasive techniques. It may also include imaging of cadaver. Minimally invasive autopsy/MITS sampling consists of collecting samples using biopsy needles from cadavers in a facility or from community deaths brought into a facility post-mortem. Samples can be tested for biomarkers including HIV, antiretrovirals (ARV), HIV drug resistance, TB, malaria, influenza, severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) and opportunistic and other infections. Moreover, multi-pathogen PCR detection cards can be used for additional pathogen identification, and MIA/MITS can help identify other CoD including cancers. A multi-country study showed that MIAs/MITS are highly acceptable as a tool to determine CoD.<sup><xref ref-type="bibr" rid="CIT0034">34</xref></sup> Samples should be collected as soon as possible and ideally within 24 h.<sup><xref ref-type="bibr" rid="CIT0035">35</xref></sup> Minimally invasive autopsy/MITS is more invasive as it collects multiple tissue and non-tissue specimen from the cadaver, whereas only blood or oral fluid is collected through biomarker surveillance.</p>
</sec>
<sec id="s20013">
<title>Human immunodeficiency viruses biomarker sentinel surveillance in mortuaries</title>
<p>Human immunodeficiency viruses (HIV) biomarker sentinel surveillance can be conducted in mortuaries through collection of blood or oral fluid and/or saliva from cadavers. All cadavers admitted to a mortuary are included in the sentinel surveillance system. Blood is collected from the heart cavity of the cadaver through a transthoracic needle, and oral fluid and/or saliva is collected from the mouth of the cadaver. The sample is then sent to a laboratory for HIV testing and, in the case of blood collection, for other biomarker testing, including viral load, ARVs and HIV drug resistance. Blood samples may additionally be tested for other non-HIV biomarkers. Information collected through the biomarker testing can be supplemented by medical records if the death occurred at a health facility; however, in the event of a community death, this information may be unavailable.</p>
</sec>
</sec>
<sec id="s0014">
<title>Conclusion</title>
<p>While LMICs work to implement CRVS, other methods can supplement or fill gaps in mortality data. The following factors could be considered when deciding which method is most feasible in the local context: methods of data collection, monitoring and storage; availability of electronic data systems versus reliance on paper-based systems; availability of laboratory infrastructure and skills; availability of human resources and technical skills of staff and availability of funding. Countries could also assess their existing infrastructure, resource availability and local mortality data need to determine the most feasible methods for implementation. In addition, cultural sensitivities around HIV and death in different communities should be considered, as acceptability of each method may vary across cultures. In LMICs, prioritising low-cost methods such as verbal autopsies or burial surveillance, combined with targeted training for local staff could help to address immediate mortality data gaps while laying the groundwork for more long-term CRVS development. Future research could potentially explore CRVS implementation challenges in LMICs, as a deeper understanding of these barriers may support more targeted and effective advocacy efforts while strengthening this gold standard system.</p>
<p>All these methods provide information on mortality generally, which includes mortality among people living with HIV and HIV as the CoD. Loss to follow-up tracking and HIV case surveillance are specific to mortality among people living with HIV and may provide information on other CoD among people living with HIV. With increasing numbers of people living with HIV in treatment and care, HIV-specific mortality data may be helpful to monitor and address gaps in epidemic control. This need has underscored the lack of consistent and routinely available mortality data. Although many of the existing mortality systems in LMICs are ad-hoc, and thus data from these systems often cannot be systematically and routinely used to inform national mortality estimates, they are still an important effort, as they provide extremely useful data that are not available otherwise. In the long run, mortality data-collection systems could be implemented in an ongoing or periodic manner so mortality data, including CoD data, are available over time. Data from these mortality methods can help prevent deaths by tailoring interventions to a particular region, disease or population.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<sec id="s20015" sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.</p>
</sec>
<sec id="s20016">
<title>Authors&#x2019; contributions</title>
<p>H.A. conceptualised the review and developed the methods with the support of M.K.. H.A., C.L.S. and D.F. wrote the first draft. Z.T., D.M., A.B. and E.A. reviewed and provided input on subsequent drafts. H.A. and M.P. provided supervision.</p>
</sec>
<sec id="s20016a">
<title>Ethical considerations</title>
<p>This article followed all ethical standards for research without direct contact with human or animal subjects.</p>
</sec>
<sec id="s20017" sec-type="data-availability">
<title>Data availability</title>
<p>Data sharing is not applicable to this article as no new data were created or analysed in this study.</p>
</sec>
<sec id="s20018">
<title>Disclaimer</title>
<p>The views and opinions expressed in this article are those of the authors and are the product of professional research. The article does not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article&#x2019;s results, findings and content.</p>
</sec>
</ack>
<ref-list id="references">
<title>References</title>
<ref id="CIT0001"><label>1</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention (CDC)</collab></person-group>. <source>Public health surveillance preparing for the future</source>. <publisher-loc>Atlanta</publisher-loc>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>; <year>2018</year>.</mixed-citation></ref>
<ref id="CIT0002"><label>2</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization, UNAIDS &#x0026; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance</collab></person-group>. <source>Surveillance of the HIV/AIDS epidemic: A comprehensive package [homepage on the Internet]</source>. <publisher-name>World Health Organization</publisher-name>; <year>2013</year> <comment>[cited 2024 Dec 06]. Available from: <ext-link ext-link-type="uri" xlink:href="https://iris.who.int/handle/10665/90893">https://iris.who.int/handle/10665/90893</ext-link></comment></mixed-citation></ref>
<ref id="CIT0003"><label>3</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>European Centre for Disease Prevention and Control, WHO Regional Office for Europe</collab></person-group>. <source>HIV/AIDS surveillance in Europe 2020 &#x2013; 2019 data</source>. <publisher-loc>Copenhagen</publisher-loc>: <publisher-name>WHO Regional Office for Europe</publisher-name>; <year>2020</year>.</mixed-citation></ref>
<ref id="CIT0004"><label>4</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>. <source>International classification of diseases 11th revision [homepage on the Internet]</source>. <publisher-name>World Health Organization</publisher-name>; <year>2021</year> <comment>[cited 2024 Jul 14]. Available from: <ext-link ext-link-type="uri" xlink:href="https://icd.who.int/en">https://icd.who.int/en</ext-link></comment></mixed-citation></ref>
<ref id="CIT0005"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adair</surname> <given-names>T</given-names></string-name></person-group>. <article-title>Who dies where? Estimating the percentage of deaths that occur at home</article-title>. <source>BMJ Glob Health</source>. <year>2021</year>;<volume>6</volume>(<issue>9</issue>):<fpage>e006766</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmjgh-2021-006766">https://doi.org/10.1136/bmjgh-2021-006766</ext-link></comment></mixed-citation></ref>
<ref id="CIT0006"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Suthar</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Khalifa</surname> <given-names>A</given-names></string-name>, <string-name><surname>Yin</surname> <given-names>S</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Evaluation of approaches to strengthen civil registration and vital statistics systems: A systematic review and synthesis of policies in 25 countries</article-title>. <source>PLoS Med</source>. <year>2019</year>;<volume>16</volume>(<issue>9</issue>):<fpage>e1002929</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1002929">https://doi.org/10.1371/journal.pmed.1002929</ext-link></comment></mixed-citation></ref>
<ref id="CIT0007"><label>7</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>. <source>Guidelines for HIV mortality measurement [homepage on the Internet]</source>. <publisher-name>World Health Organization</publisher-name>; <year>2014</year> <comment>[cited 2024 Jul 13]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK236997/">https://www.ncbi.nlm.nih.gov/books/NBK236997/</ext-link></comment></mixed-citation></ref>
<ref id="CIT0008"><label>8</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>UNAIDS</collab></person-group>. <source>National HIV estimates file [homepage on the Internet]</source>. <publisher-name>UNAIDS</publisher-name>; <year>2022</year> <comment>[cited 2024 Jul 14]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/resources/documents/2023/2022_unaids_data">https://www.unaids.org/en/resources/documents/2023/2022_unaids_data</ext-link></comment></mixed-citation></ref>
<ref id="CIT0009"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grant</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Booth</surname> <given-names>A</given-names></string-name></person-group>. <article-title>A typology of reviews: An analysis of 14 review types and associated methodologies</article-title>. <source>Health Info Libr J</source>. <year>2009</year>;<volume>26</volume>(<issue>2</issue>):<fpage>91</fpage>&#x2013;<lpage>108</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1471-1842.2009.00848.x">https://doi.org/10.1111/j.1471-1842.2009.00848.x</ext-link></comment></mixed-citation></ref>
<ref id="CIT0010"><label>10</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>United Nations</collab></person-group>. <source>Population and vital statistics report [homepage on the Internet]</source>. <publisher-name>United Nations</publisher-name>; <year>2016</year> <comment>[cited 2024 Jul 14]. Available from: <ext-link ext-link-type="uri" xlink:href="https://unstats.un.org/unsd/demographic-social/products/vitstats/sets/Series_A_2016.pdf">https://unstats.un.org/unsd/demographic-social/products/vitstats/sets/Series_A_2016.pdf</ext-link></comment></mixed-citation></ref>
<ref id="CIT0011"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harklerode</surname> <given-names>R</given-names></string-name>, <string-name><surname>Schwarcz</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hargreaves</surname> <given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Feasibility of establishing HIV case-based surveillance to measure progress along the health sector cascade: Situational assessments in Tanzania, South Africa, and Kenya</article-title>. <source>JMIR Public Health Surveill</source>. <year>2017</year>;<volume>3</volume>(<issue>3</issue>):<fpage>e44</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2196/publichealth.7610">https://doi.org/10.2196/publichealth.7610</ext-link></comment></mixed-citation></ref>
<ref id="CIT0012"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gebrekidan</surname> <given-names>TA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Mortality surveillance practices for measuring the demographic impact of HIV/AIDS in sub-Saharan Africa</article-title>. <source>jHASE</source>. <year>2010</year>;<volume>2</volume>(<issue>1</issue>):<fpage>9</fpage>.</mixed-citation></ref>
<ref id="CIT0013"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Araya</surname> <given-names>T</given-names></string-name>, <string-name><surname>Reniers</surname> <given-names>G</given-names></string-name>, <string-name><surname>Schaap</surname> <given-names>A</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Lay diagnosis of causes of death for monitoring AIDS mortality in Addis Ababa, Ethiopia</article-title>. <source>Trop Med Int Health</source>. <year>2004</year>;<volume>9</volume>(<issue>1</issue>):<fpage>178</fpage>&#x2013;<lpage>186</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1046/j.1365-3156.2003.01172.x">https://doi.org/10.1046/j.1365-3156.2003.01172.x</ext-link></comment></mixed-citation></ref>
<ref id="CIT0014"><label>14</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Office of Population Research at Princeton University</collab></person-group>. <source>Addis Ababa mortality surveillance project (AAMSP) [homepage on the Internet]</source>. <publisher-name>Princeton University</publisher-name>; <year>2021</year> <comment>[cited 2024 Jul 14]. Available from: <ext-link ext-link-type="uri" xlink:href="https://oprdata.princeton.edu/archive/aamsp/">https://oprdata.princeton.edu/archive/aamsp/</ext-link></comment></mixed-citation></ref>
<ref id="CIT0015"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kahn</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tollman</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Collinson</surname> <given-names>MA</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Research into health, population and social transitions in rural South Africa: Data and methods of the Agincourt Health and Demographic Surveillance System</article-title>. <source>Scand J Public Health Suppl</source>. <year>2007</year>;<volume>69</volume>:<fpage>8</fpage>&#x2013;<lpage>20</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14034950701505031">https://doi.org/10.1080/14034950701505031</ext-link></comment></mixed-citation></ref>
<ref id="CIT0016"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hill</surname> <given-names>K</given-names></string-name>, <string-name><surname>El Arifeen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Koenig</surname> <given-names>M</given-names></string-name>, <string-name><surname>Al-Sabir</surname> <given-names>A</given-names></string-name>, <string-name><surname>Jamil</surname> <given-names>K</given-names></string-name>, <string-name><surname>Raggers</surname> <given-names>H</given-names></string-name></person-group>. <article-title>How should we measure maternal mortality in the developing world? A comparison of household deaths and sibling history approaches</article-title>. <source>Bull World Health Organ</source>. <year>2006</year>;<volume>84</volume>(<issue>3</issue>):<fpage>173</fpage>&#x2013;<lpage>180</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2471/BLT.05.027714">https://doi.org/10.2471/BLT.05.027714</ext-link></comment></mixed-citation></ref>
<ref id="CIT0017"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baschieri</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gordeev</surname> <given-names>VS</given-names></string-name>, <string-name><surname>Akuze</surname> <given-names>J</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>&#x2018;Every Newborn-INDEPTH&#x2019; (EN-INDEPTH) study protocol for a randomised comparison of household survey modules for measuring stillbirths and neonatal deaths in five Health and Demographic Surveillance sites</article-title>. <source>J Glob Health</source>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>010901</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7189/jogh.09.010901">https://doi.org/10.7189/jogh.09.010901</ext-link></comment></mixed-citation></ref>
<ref id="CIT0018"><label>18</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>German Institute of Medical Documentation and Information</collab></person-group>. <source>About Iris [homepage on the Internet]</source>. <publisher-name>German Institute of Medical Documentation and Information</publisher-name>; <year>2014</year> <comment>[cited 2024 Jul 14]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.dimdi.de/static/en/klassi/koop/irisinstitute/about-iris/index.htm">http://www.dimdi.de/static/en/klassi/koop/irisinstitute/about-iris/index.htm</ext-link></comment></mixed-citation></ref>
<ref id="CIT0019"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tosif</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jatobatu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Maepioh</surname> <given-names>A</given-names></string-name>, <string-name><surname>Subhi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Francis</surname> <given-names>KL</given-names></string-name>, <string-name><surname>Duke</surname> <given-names>T</given-names></string-name></person-group>. <article-title>Cause-specific neonatal morbidity and mortality in the Solomon Islands: An assessment of data from four hospitals over a three-year period</article-title>. <source>J Paediatr Child Health</source>. <year>2020</year>;<volume>56</volume>(<issue>4</issue>):<fpage>607</fpage>&#x2013;<lpage>614</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jpc.14699">https://doi.org/10.1111/jpc.14699</ext-link></comment></mixed-citation></ref>
<ref id="CIT0020"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mboera</surname> <given-names>LEG</given-names></string-name>, <string-name><surname>Rumisha</surname> <given-names>SF</given-names></string-name>, <string-name><surname>Lyimo</surname> <given-names>EP</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Cause-specific mortality patterns among hospital deaths in Tanzania, 2006&#x2013;2015</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>10</issue>):<fpage>e0205833</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0205833">https://doi.org/10.1371/journal.pone.0205833</ext-link></comment></mixed-citation></ref>
<ref id="CIT0021"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stewart</surname> <given-names>K</given-names></string-name>, <string-name><surname>Choudry</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Buckingham</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Learning from hospital mortality</article-title>. <source>Clin Med</source>. <year>2016</year>;<volume>16</volume>(<issue>6</issue>):<fpage>530</fpage>&#x2013;<lpage>534</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7861/clinmedicine.16-6-530">https://doi.org/10.7861/clinmedicine.16-6-530</ext-link></comment></mixed-citation></ref>
<ref id="CIT0022"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holmes</surname> <given-names>CB</given-names></string-name>, <string-name><surname>Sikazwe</surname> <given-names>I</given-names></string-name>, <string-name><surname>Sikombe</surname> <given-names>K</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based survey</article-title>. <source>PLoS Med</source>. <year>2018</year>;<volume>15</volume>(<issue>1</issue>):<fpage>e1002489</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1002489">https://doi.org/10.1371/journal.pmed.1002489</ext-link></comment></mixed-citation></ref>
<ref id="CIT0023"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anderegg</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hector</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jefferys</surname> <given-names>LF</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Loss to follow-up correction increased mortality estimates in HIV-positive people on antiretroviral therapy in Mozambique</article-title>. <source>J Clin Epidemiol</source>. <year>2020</year>;<volume>128</volume>:<fpage>83</fpage>&#x2013;<lpage>92</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jclinepi.2020.08.012">https://doi.org/10.1016/j.jclinepi.2020.08.012</ext-link></comment></mixed-citation></ref>
<ref id="CIT0024"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weigel</surname> <given-names>R</given-names></string-name>, <string-name><surname>Hochgesang</surname> <given-names>M</given-names></string-name>, <string-name><surname>Brinkhof</surname> <given-names>MW</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi</article-title>. <source>BMC Infect Dis</source>. <year>2011</year>;<volume>11</volume>:<fpage>31</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2334-11-31">https://doi.org/10.1186/1471-2334-11-31</ext-link></comment></mixed-citation></ref>
<ref id="CIT0025"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brinkhof</surname> <given-names>MWG</given-names></string-name>, <string-name><surname>Pujades-Rodriguez</surname> <given-names>M</given-names></string-name>, <string-name><surname>Egger</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: Systematic review and meta-analysis</article-title>. <source>PLoS One</source>. <year>2009</year>;<volume>4</volume>(<issue>6</issue>):<fpage>e5790</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0005790">https://doi.org/10.1371/journal.pone.0005790</ext-link></comment></mixed-citation></ref>
<ref id="CIT0026"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nsubuga</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mabaya</surname> <given-names>S</given-names></string-name>, <string-name><surname>Apollo</surname> <given-names>T</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Evaluation of the Zimbabwe HIV case surveillance pilot project, 2019</article-title>. <source>Pan Afr Med J</source>. <year>2020</year>;<volume>37</volume>:<fpage>353</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11604/pamj.2020.37.353.25600">https://doi.org/10.11604/pamj.2020.37.353.25600</ext-link></comment></mixed-citation></ref>
<ref id="CIT0027"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zaitoun</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Fernandez</surname> <given-names>C</given-names></string-name></person-group>. <article-title>The value of histological examination in the audit of hospital autopsies: A quantitative approach</article-title>. <source>Pathology</source>. <year>1998</year>;<volume>30</volume>(<issue>2</issue>):<fpage>100</fpage>&#x2013;<lpage>104</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/00313029800169036">https://doi.org/10.1080/00313029800169036</ext-link></comment></mixed-citation></ref>
<ref id="CIT0028"><label>28</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>. <source>Verbal autopsy standards: The 2016 WHO verbal autopsy instrument [homepage on the Internet]</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2016</year> <comment>[cited 2024 Dec 06]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/m/item/verbal-autopsy-standards-the-2016-who-verbal-autopsy-instrument">https://www.who.int/publications/m/item/verbal-autopsy-standards-the-2016-who-verbal-autopsy-instrument</ext-link></comment></mixed-citation></ref>
<ref id="CIT0029"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Desai</surname> <given-names>N</given-names></string-name>, <string-name><surname>Aleksandrowicz</surname> <given-names>L</given-names></string-name>, <string-name><surname>Miasnikof</surname> <given-names>P</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Performance of four computer-coded verbal autopsy methods for cause of death assignment compared with physician coding on 24,000 deaths in low- and middle-income countries</article-title>. <source>BMC Med</source>. <year>2014</year>;<volume>12</volume>:<fpage>20</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1741-7015-12-20">https://doi.org/10.1186/1741-7015-12-20</ext-link></comment></mixed-citation></ref>
<ref id="CIT0030"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uneke</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Uro-Chukwu</surname> <given-names>HC</given-names></string-name>, <string-name><surname>Chukwu</surname> <given-names>OE</given-names></string-name></person-group>. <article-title>Validation of verbal autopsy methods for assessment of child mortality in sub-Saharan Africa and the policy implication: A rapid review</article-title>. <source>Pan Afr Med J</source>. <year>2019</year>;<volume>33</volume>:<fpage>318</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11604/pamj.2019.33.318.16405">https://doi.org/10.11604/pamj.2019.33.318.16405</ext-link></comment></mixed-citation></ref>
<ref id="CIT0031"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Murray</surname> <given-names>CJL</given-names></string-name>, <string-name><surname>Lozano</surname> <given-names>R</given-names></string-name>, <string-name><surname>Flaxman</surname> <given-names>AD</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Using verbal autopsy to measure causes of death: The comparative performance of existing methods</article-title>. <source>BMC Med</source>. <year>2014</year>;<volume>12</volume>:<fpage>5</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1741-7015-12-5">https://doi.org/10.1186/1741-7015-12-5</ext-link></comment></mixed-citation></ref>
<ref id="CIT0032"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Murray</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Lopez</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Black</surname> <given-names>R</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Population Health Metrics Research Consortium gold standard verbal autopsy validation study: Design, implementation, and development of analysis datasets</article-title>. <source>Popul Health Metr</source>. <year>2011</year>;<volume>9</volume>:<fpage>27</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1478-7954-9-27">https://doi.org/10.1186/1478-7954-9-27</ext-link></comment></mixed-citation></ref>
<ref id="CIT0033"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gouda</surname> <given-names>HN</given-names></string-name>, <string-name><surname>Flaxman</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Brolan</surname> <given-names>CE</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>New challenges for verbal autopsy: Considering the ethical and social implications of verbal autopsy methods in routine health information systems</article-title>. <source>Soc Sci Med</source>. <year>2017</year>;<volume>184</volume>:<fpage>65</fpage>&#x2013;<lpage>74</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.socscimed.2017.05.002">https://doi.org/10.1016/j.socscimed.2017.05.002</ext-link></comment></mixed-citation></ref>
<ref id="CIT0034"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maixenchs</surname> <given-names>M</given-names></string-name>, <string-name><surname>Anselmo</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zielinski-Guti&#x00E9;rrez</surname> <given-names>E</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Willingness to know the cause of death and hypothetical acceptability of the minimally invasive autopsy in six diverse African and Asian settings: A mixed methods socio-behavioural study</article-title>. <source>PLoS Med</source>. <year>2016</year>;<volume>13</volume>(<issue>11</issue>):<fpage>e1002172</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pmed.1002172">https://doi.org/10.1371/journal.pmed.1002172</ext-link></comment></mixed-citation></ref>
<ref id="CIT0035"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saegeman</surname> <given-names>V</given-names></string-name>, <string-name><surname>Cohen</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Burton</surname> <given-names>JL</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Microbiology in minimally invasive autopsy: Best techniques to detect infection. ESGFOR (ESCMID study group of forensic and post-mortem microbiology) guidelines</article-title>. <source>Forensic Sci Med Pathol</source>. <year>2021</year>;<volume>17</volume>(<issue>1</issue>):<fpage>87</fpage>&#x2013;<lpage>100</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12024-020-00337-x">https://doi.org/10.1007/s12024-020-00337-x</ext-link></comment></mixed-citation></ref>
<ref id="CIT0036"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karat</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Tlali</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fielding</surname> <given-names>KL</given-names></string-name>, <etal>et al</etal></person-group>. <article-title>Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>3</issue>):<fpage>e0174097</fpage>. <comment><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0174097">https://doi.org/10.1371/journal.pone.0174097</ext-link></comment></mixed-citation></ref>
</ref-list>
<fn-group>
<fn><p><bold>How to cite this article:</bold> Sulpizio CL, Tessema Z, Morof D, et al. What are our options for mortality data collection and how can they provide HIV-specific information? J Public Health Africa. 2025;16(1), a733. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4102/jphia.v16i1.733">https://doi.org/10.4102/jphia.v16i1.733</ext-link></p></fn>
</fn-group>
</back>
</article>